Research ArticleClinical Studies
Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up
FEDERICO AMPIL, SHEHANAZ ELLIKA, ANIL NANDA and MOIZ VORA
Anticancer Research September 2017, 37 (9) 5113-5115;
FEDERICO AMPIL
Departments of Radiology, Neurosurgery and Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A.
SHEHANAZ ELLIKA
Departments of Radiology, Neurosurgery and Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A.
ANIL NANDA
Departments of Radiology, Neurosurgery and Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A.
MOIZ VORA
Departments of Radiology, Neurosurgery and Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, U.S.A.
In this issue
Anticancer Research
Vol. 37, Issue 9
September 2017
Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up
FEDERICO AMPIL, SHEHANAZ ELLIKA, ANIL NANDA, MOIZ VORA
Anticancer Research Sep 2017, 37 (9) 5113-5115;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
- Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain Radiotherapy
- Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement
- Patterns of Treatment and Outcome in Patients With 20 or More Brain Metastases
- Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases